MoonLake Immunotherapeutics SEC filings MLTX
MoonLake Immunotherapeutics has 331 filings in SEC EDGAR's recent list, going back to Aug 28, 2020. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Other events
|
Sep 30, 2026 | Sep 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| S-8 | Employee stock plan registration | Aug 10, 2026 | — |
| S-3ASR | Automatic shelf registration | Aug 10, 2026 | — |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 10, 2026 | Aug 10, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 23, 2026 | Jul 21, 2026 |
| 4 | Insider transaction | Jul 21, 2026 | Jul 20, 2026 |
| 4 | Insider transaction | Jul 20, 2026 | Jul 15, 2026 |
| 144 | Notice of proposed sale | Jul 15, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 15, 2026 | Jul 14, 2026 |
| 4 | Insider transaction | Jul 13, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 144 | Notice of proposed sale | Jun 30, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 29, 2026 | — |
| 8-K |
Current report
Material agreement
|
Jun 25, 2026 | Jun 23, 2026 |
| 424B5 | Prospectus supplement | Jun 24, 2026 | — |
| 4 | Insider transaction | Jun 23, 2026 | Jun 22, 2026 |
| 424B5 | Prospectus supplement | Jun 22, 2026 | — |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 22, 2026 | Jun 21, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 15, 2026 |
| 144 | Notice of proposed sale | Jun 15, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 9, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Material agreement
|
Jun 1, 2026 | May 22, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 4 | Insider transaction | May 13, 2026 | May 11, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 11, 2026 | May 10, 2026 |
| ARS | Annual report to shareholders | Apr 21, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEF 14A | Proxy statement | Apr 21, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 14, 2026 |
| 4 | Insider transaction | Apr 14, 2026 | Apr 10, 2026 |
| 4 | Insider transaction | Apr 10, 2026 | Apr 9, 2026 |
| 144 | Notice of proposed sale | Apr 10, 2026 | — |
| 144 | Notice of proposed sale | Apr 9, 2026 | — |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 2, 2026 | — |
| 144 | Notice of proposed sale | Mar 31, 2026 | — |
| 10-K | Annual report | Feb 25, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Officer or director change, Regulation FD disclosure, Other events
|
Feb 23, 2026 | Feb 18, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Other events
|
Jan 8, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 19, 2025 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 19, 2025 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 19, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 144 | Notice of proposed sale | Dec 8, 2025 | — |
| 144 | Notice of proposed sale | Dec 8, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 12, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 10, 2025 | — |
| 8-K |
Current report
Material agreement
|
Nov 5, 2025 | Nov 5, 2025 |
| 424B5 | Prospectus supplement | Nov 5, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2025 | — |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Oct 9, 2025 | Oct 8, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 1, 2025 | — |
| 4 | Insider transaction | Oct 1, 2025 | Sep 29, 2025 |
| 8-K |
Current report
Other events
|
Sep 29, 2025 | Sep 29, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 2, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2025 | — |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Jul 7, 2025 | Jul 3, 2025 |
| 144 | Notice of proposed sale | Jul 3, 2025 | — |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 29, 2025 | Apr 29, 2025 |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 22, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Apr 3, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 10-K | Annual report | Feb 26, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2025 | Feb 26, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 4 | Insider transaction | Jan 22, 2025 | Jan 20, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 18, 2024 | Dec 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 4 | Insider transaction | Oct 8, 2024 | Oct 4, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 8, 2024 | — |
| 4 | Insider transaction | Oct 8, 2024 | Oct 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 11, 2024 | Sep 11, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 10, 2024 | Jun 10, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 5, 2024 |
| UPLOAD | Letter from the SEC | May 13, 2024 | — |
| CORRESP | Letter to the SEC | May 7, 2024 | — |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| 10-K/A | Amended annual report | May 7, 2024 | Dec 31, 2023 |
| UPLOAD | Letter from the SEC | Apr 29, 2024 | — |
| ARS | Annual report to shareholders | Apr 24, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 24, 2024 | — |
| DEF 14A | Proxy statement | Apr 24, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 11, 2024 | Mar 10, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 5, 2024 | — |
| 4 | Insider transaction | Feb 29, 2024 | Feb 27, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 27, 2024 |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 26, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 23, 2024 | Feb 21, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 20, 2024 | Feb 15, 2024 |
| 4 | Insider transaction | Feb 16, 2024 | Feb 14, 2024 |
| 144 | Notice of proposed sale | Feb 15, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 15, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| 144 | Notice of proposed sale | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2024 | — |
| 4 | Insider transaction | Dec 21, 2023 | Dec 19, 2023 |
| 144 | Notice of proposed sale | Dec 20, 2023 | — |
| 144 | Notice of proposed sale | Dec 19, 2023 | — |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 6, 2023 | Nov 5, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 16, 2023 | Oct 15, 2023 |
| 4 | Insider transaction | Oct 10, 2023 | Oct 5, 2023 |
| 4 | Insider transaction | Oct 4, 2023 | Oct 2, 2023 |
| 4 | Insider transaction | Oct 3, 2023 | Oct 1, 2023 |
| 4 | Insider transaction | Oct 3, 2023 | Oct 1, 2023 |
| 4 | Insider transaction | Oct 3, 2023 | Oct 1, 2023 |
| 4 | Insider transaction | Oct 3, 2023 | Oct 1, 2023 |
| EFFECT | Filing | Sep 11, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 11, 2023 | Sep 11, 2023 |
| CORRESP | Letter to the SEC | Sep 7, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 6, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Sep 1, 2023 | Aug 30, 2023 |
| S-3 | Shelf registration | Aug 31, 2023 | — |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 4 | Insider transaction | Jul 5, 2023 | Jun 30, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Jun 30, 2023 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jun 29, 2023 | Jun 27, 2023 |
| 424B5 | Prospectus supplement | Jun 29, 2023 | — |
| 4 | Insider transaction | Jun 28, 2023 | Jun 26, 2023 |
| 424B3 | Prospectus | Jun 27, 2023 | — |
| 424B5 | Prospectus supplement | Jun 26, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 26, 2023 | Jun 26, 2023 |
| 4 | Insider transaction | Jun 12, 2023 | Jun 8, 2023 |
| 4 | Insider transaction | Jun 12, 2023 | Jun 8, 2023 |
| 4 | Insider transaction | Jun 12, 2023 | Jun 8, 2023 |
| 4 | Insider transaction | Jun 12, 2023 | Jun 8, 2023 |
| 4 | Insider transaction | Jun 12, 2023 | Jun 8, 2023 |
| 4 | Insider transaction | Jun 12, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Officer or director change
|
May 19, 2023 | May 15, 2023 |
| 424B5 | Prospectus supplement | May 11, 2023 | — |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| EFFECT | Filing | May 9, 2023 | — |
| CORRESP | Letter to the SEC | May 5, 2023 | — |
| EFFECT | Filing | May 4, 2023 | — |
| UPLOAD | Letter from the SEC | May 4, 2023 | — |
| S-3 | Shelf registration | May 1, 2023 | — |
| POS AM | Filing | May 1, 2023 | — |
| ARS | Annual report to shareholders | Apr 26, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2023 | — |
| DEF 14A | Proxy statement | Apr 26, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 19, 2023 | Apr 19, 2023 |
| 4 | Insider transaction | Apr 7, 2023 | Apr 5, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MLTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Zug, Switzerland
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1821586
- Former names
- Helix Acquisition Corp (until Mar 31, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.